Late-onset neutropenia following rituximab

被引：8
|
作者：
McLaughlin, Peter [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
LEUKEMIA & LYMPHOMA | 2006年 / 47卷 / 06期
关键词：
D O I：
10.1080/10428190600649349
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：965 / 966
页数：2
相关论文
共 50 条
  • [41] Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab
    Auer, Michael
    Bsteh, Gabriel
    Hegen, Harald
    Wurth, Sebastian
    Zinganell, Anne
    Berger, Thomas
    Deisenhammer, Florian
    Di Pauli, Franziska
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
  • [42] Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis
    Daniel Tesfa
    Tobias Gelius
    Birgitta Sander
    Eva Kimby
    Bengt Fadeel
    Jan Palmblad
    Hans Hägglund
    Medical Oncology, 2008, 25 : 374 - 379
  • [43] Rituximab- and ocrelizumab-induced early- and late-onset neutropenia in a multiple sclerosis patient
    Mariano Marrodan
    Julia Laviano
    Sofía Oneto
    Fabricio M. Reino
    Ricardo Delorme
    Florencia Fornillo
    José Férnandez
    Jorge Correale
    Neurological Sciences, 2021, 42 : 3893 - 3895
  • [44] Late-Onset Neutropenia and Acute Rejection in ABO-Incompatible Kidney Transplant Recipients Receiving Rituximab
    Iwai, T.
    Uchida, J.
    Kabei, K.
    Kohyama, Y.
    Okamura, M.
    Nin, Y.
    Iguchi, K.
    Shimizu, Y.
    Yukimatsu, N.
    Yamasaki, T.
    Kuwabara, N.
    Naganuma, T.
    Kumada, N.
    Nakatani, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 450 - 450
  • [45] LATE-ONSET NEUTROPENIA AFTER RITUXIMAB TREATMENT IN B-CELL LYMPHOMA: A SINGLE CENTRE EXPERIENCE
    Perrone, T.
    Gaudio, F.
    Scardino, S.
    Mastrorosa, A.
    Spina, A.
    Laddaga, F.
    Ingravallo, G.
    Cimmino, A.
    Specchia, G.
    HAEMATOLOGICA, 2012, 97 : 668 - 668
  • [46] Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab
    Auer, M.
    Bsteh, G.
    Hegen, H.
    Wurth, S.
    Zinganell, A.
    Berger, T.
    Deisenhammer, F.
    Di Pauli, F.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 287 - 287
  • [47] The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
    Tesfa, Daniel
    Sander, Birgitta
    Lindkvist, Henric
    Nilsson, Christer
    Kimby, Eva
    Hagglund, Hans
    Wahlin, Bjorn E.
    Klimkowska, Monika
    Palmblad, Jan
    MEDICAL ONCOLOGY, 2021, 38 (06)
  • [48] Late-Onset Neutropenia and Acute Rejection in ABO-Incompatible Kidney Transplant Recipients Receiving Rituximab
    Iwai, T.
    Uchida, J.
    Kabei, K.
    Kohyama, Y.
    Okamura, M.
    Nin, Y.
    Iguchi, K.
    Shimizu, Y.
    Yukimatsu, N.
    Yamasaki, T.
    Kuwabara, N.
    Naganuma, T.
    Kumada, N.
    Nakatani, T.
    TRANSPLANTATION, 2014, 98 : 450 - 450
  • [49] Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL
    Parodis, I.
    Soder, F.
    Faustini, F.
    Kasza, Z.
    Samuelsson, I.
    Zickert, A.
    Svenungsson, E.
    van Vollenhoven, R. F.
    Malmstrom, V.
    Wermeling, F.
    Gunnarsson, I.
    LUPUS, 2018, 27 (09) : 1470 - 1478
  • [50] Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis
    Tesfa, Daniel
    Gelius, Tobias
    Sander, Birgitta
    Kimby, Eva
    Fadeel, Bengt
    Palmblad, Jan
    Hagglund, Hans
    MEDICAL ONCOLOGY, 2008, 25 (04) : 374 - 379
12345